Lilly receives FDA’s breakthrough therapy designation for ovarian cancer drug

Please subscribe to IBJ to decode this article.

Clid r.nvtdtnodcvtsr Etgdosaa innetioahrnoinia llr htrt yreteaaouDpovgd. estoi r.S datirb'mheeahinuy cuio nAg p aem .Fnpnikeesr te edldc trofhest n a cogrieaieLaraaUn

r aocnv skrrcapTotm r,iafa tnttobisuieviulisrseot arbrfe veenv tteetidlhtib doingat bhpaiamburbln itceypmdameaart a rsuheormlaeg ueho w ntonoTe an,ni ttiayeaiassr lmtelmnpa mglhe dpffhd-os eI seetce dipiendsxpti,si opid tllriieaievabeti nwcoeenaz-i oprruuha.franacsenaarevdair in atail eav

set t ispestss oaf eet ptpnxh ul bidi Dvne ngc reo u ii idetehn oryacmvpshlt mreemsoieedad ’onstist uascg aAnegngFr.ifsgirnaetrcavrr ln drriisarlikeehmpidhartteiieioepandhalTh daee aoteirnmpuiaiec nmat fittdel ydnuao enetbglo rahe ooew v r owaehvtvbeic

csaorspinm .intc eiie taa rudsm ilsnlOnsvlno1eagDtehn uiei oiTdtaaeowia wptdne,gtsersct nshe teieL teelhcaamearpnnaneflntatdu vtrnsr c ioyrm e pi“ so dirn taee ro esrd adnshe stetN sdserlg pr a nep i lfumfs taoeeFaVeAnmbta osg oieh aeet ffa nory-grtitnitneiylPbdetriahJsdh ean ri unofahhg i hiW nonsnrdgkBatu,ucnttbyapnracor atcnleo,,adi”noa iep

arasthoehtenpsa i eohueroligoUnen tttgsiLa benin betlO,irascrearseoteix nelp eacac medliptom esnb tl gSr.wftdt aeoen eeiyenpru-t-echerp u.hc,euoni iclnist eeoiiaeli ymf cmia7 ud r aoin n mfrua sssntiehtehsdi el qtdccya%w d ettianl thrstai aemreasrbtnv u0osn cmhpnadtwdort

hry-t nuissgto ean rttnpeilurhnnieir e n adtslxomc tetarwstuPowhi ie icncmdnitp ma uooiansrkrsien faefe.coptdtnmerit alss eptse,msiawn aatn h

,C fspiTtcnod eNtne ienlfeo aCc honamls sa tlic alt edrt r g hlasPerdlmsntoueoheict v -ioueytot,itinm Pieniooa htPUorctc"n iaehgngtlh roaennvra ies“rg s s iaaa hilrYotfatawcaL t og nmclaio,wse gnitre hB tos aieCo i r,ane c eenHtprntlnnmnta.mrclifn trieutnmsntaedsorr tttepau trot igefci oy nonnmeeetaaet iO

ot/ kboh pnnso eFaaanc mcn’tpu bsibinryot ld eunom,m hlsithhdst h Ar yaeTi.aw1taylciit pneoialsebePitirrst PfnL ttshsle da,udgye3 hecrlfydy g y a sni ortaaocvegdrrirseLacreuseaofdaa h’Derl is